Association of hormone replacement therapy with the risk of gastric cancer: a systematic review and meta-analysis

  • Sung, H. et al. World Cancer Statistics 2020: GLOBOCAN estimates of worldwide incidence and mortality for 36 cancers in 185 countries. CA A Cancer J. Clin. 71209–249 (2021).

    Google Scholar article

  • Thrift, AP & El-Serag, HB Burden of gastric cancer. Clin. Gastroenterol. Hepatol. 18534-542 (2020).

    PubMedGoogle Scholar Article

  • Zhang, X. et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology 155347–354 (2018).

    PubMedGoogle Scholar Article

  • Huang, HL et al. Effect and cost-effectiveness of nationwide gastric cancer screening in Japan: a microsimulation modeling study. BMC Med. 18257 (2020).

    PubMed PubMed Central ArticleGoogle Scholar

  • Arnold, M. et al. Is gastric cancer becoming a rare disease? A global assessment of projected incidence trends to 2035. Intestine 69823–829 (2020).

    PubMedGoogle Scholar Article

  • Ferlay, J. et al. World Cancer Observatory: Cancer tomorrow. Lyon, France: International Agency for Research on Cancer (2020). https://gco.iarc.fr/tomorrow. Accessed November 18, 2021.

  • Lobo, RA Hormone replacement therapy: current thinking. Nat. Rev. Endocrinol. 13220-231 (2017).

    CAS PubMed Google Scholar Article

  • Wells, G. et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the effectiveness of hormone replacement therapy in the treatment and prevention of osteoporosis in postmenopausal women. Endocrine Rev. 23529–539 (2002).

    CAS Google Scholar Article

  • Collaborative group on epidemiological studies of ovarian cancer. Use of menopausal hormones and risk of ovarian cancer: individual meta-analysis of 52 epidemiological studies. Lancet 3851835–1842 (2015).

    PubMed Central CAS Article Google Scholar

  • Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: an individual participant meta-analysis of global epidemiological data. Lancet 3941159-1168 (2019).

    PubMed Central ArticleGoogle Scholar

  • Lagergren, K., Lagergren, J. & Brusselaers, N. Hormone replacement therapy and oral contraceptives and risk of esophageal adenocarcinoma: systematic review and meta-analysis. Int. J.Cancer 1352183-2190 (2014).

    CAS PubMed Google Scholar Article

  • Johnson, J.R. et al. Menopausal hormone therapy and risk of colorectal cancer. Cancer epidemiology. Biomark. Prev. 18196–203 (2009).

    CAS Google Scholar Article

  • Jang, YC, Huang, HL & Leung, CY Association of hormone replacement therapy with mortality in colorectal cancer survivors: a systematic review and meta-analysis. CMB Cancer 191199 (2019).

    CAS PubMed PubMed Central Google Scholar Article

  • Chlebowski, RT et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N.Engl. J.Med. 350991–1004 (2004).

    CAS PubMed Google Scholar Article

  • Grodstein, F., Newcomb, PA & Stampfer, MJ Postmenopausal hormone therapy and colorectal cancer risk: a review and meta-analysis. A m. J.Med. 106574–582 (1999).

    CAS PubMed Google Scholar Article

  • Camargo, MC et al. Sex hormones, hormonal interventions and gastric cancer risk: a meta-analysis. Cancer epidemiology. Biomark. Prev. 2120–38 (2012).

    CAS Google Scholar Article

  • Brusselaers, N., Maret-Ouda, J., Konings, P., El-Serag, HB & Lagergren, J. Hormonal treatment of menopause and risk of esophageal and stomach cancer. Int. J.Cancer 1401693–1699 (2017).

    CAS PubMed Google Scholar Article

  • Wang, Z. et al. Reproductive factors, hormone use and gastric cancer risk: the Singapore Chinese Health Study. Int. J.Cancer 1382837–2845 (2016).

    CAS PubMed PubMed Central Google Scholar Article

  • Lopez, V. et al. Menstrual and reproductive factors and risk of gastric and colorectal cancer in Spain. PLoS One 11e0164620 (2016).

    PubMed PubMed Central CAS Article Google Scholar

  • Wells, G., Shea, B., and O’Connell, D. Proceedings of the Third Symposium on Systematic Reviews. Beyond the Basics: Improving Quality and Impact. Oxford: The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. (2000).

  • Higgins, JP & Thompson, SG Quantification of heterogeneity in a meta-analysis. Med Statistics 211539-1558 (2002).

    PubMedGoogle Scholar Article

  • IntHout, J., Ioannidis, JP, Rovers, MM & Goeman, JJ A case for the systematic presentation of prediction intervals in meta-analysis. BMJ open 6e010247 (2016).

    PubMed PubMed Central ArticleGoogle Scholar

  • Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple graphical test. BMJ 315629–634 (1997).

    CAS PubMed PubMed Central Google Scholar Article

  • Duval, S. & Tweedie, R. Trim and fill: A simple funnel chart method to test and adjust for publication bias in meta-analysis. Biometrics 56455–463 (2000).

    CASE PubMed MATH Google Scholar Article

  • Patsopoulos, NA, Evangelou, E. & Ioannidis, JP Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical assessment. Int. J. Epidemiol. 371148–1157 (2008).

    PubMed PubMed Central ArticleGoogle Scholar

  • Kaneko, S., Tamakoshi, A., Ohno, Y., Mizoue, T. & Yoshimura, T. Menstrual and reproductive factors and gastric cancer mortality risk in Japanese postmenopausal women. Control of the causes of cancer 1453–59 (2003).

    PubMedGoogle Scholar Article

  • LaVechia, C. et al. Menstrual and reproductive factors and gastric cancer risk in women. Int. J.Cancer 59761–764 (1994).

    PubMedGoogle Scholar Article

  • Lindblad, M., Rodriguez, LG, Chandanos, E. & Lagergren, J. Hormone replacement therapy and risks of esophageal and gastric adenocarcinomas. Br. J. Cancer 94136–141 (2006).

    CAS PubMed Google Scholar Article

  • Duelle, EJ et al. Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Cancer and Nutrition Survey. A m. J. Epidemiol. 1721384–1393 (2010).

    PubMedGoogle Scholar Article

  • Freedman, North Dakota et al. The association of menstrual and reproductive factors with cancers of the upper gastrointestinal tract in the NIH-AARP cohort. Interdisciplinary cancerology. Int. Jam. Cancer Society 1161572-1581 (2010).

    Google Scholar

  • Freedman, North Dakota et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Intestine 561671-1677 (2007).

    PubMed PubMed Central ArticleGoogle Scholar

  • Nam, JH et al. The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study. BMC Gastroenterol. 211–2 (2021).

    CAS Google Scholar Article

  • Green, J. et al. Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort and meta-analysis. Int. J.Cancer 1302387–2396 (2012).

    CAS PubMed Google Scholar Article

  • Frize, S., Kreiger, N., Gallinger, S., Tomlinson, G. & Cotterchio, M. Menstrual and reproductive risk factors and risk of gastric adenocarcinoma in women: results from the Canadian national enhanced cancer surveillance system . Anna. Epidemiol. 16908–916 (2006).

    PubMedGoogle Scholar Article

  • Fernandez, E. et al. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int. J.Cancer 105408–412 (2003).

    CAS PubMed Google Scholar Article

  • Grossman, D.C. et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force recommendation statement. JAMA 3182224-2233 (2017).

    PubMedGoogle Scholar Article

  • Rymer, J., Brian, K. & Regan, L. HRT and breast cancer risk. BMJ 36725 (2019).

    Google Scholar

  • Hamoda, H. & Moger, S. Looking at HRT in perspective. BMJ 377o1425 (2022).

    PubMedGoogle Scholar Article

  • Fitzmaurice, C. et al. Global, regional and national cancer incidence, mortality, years of life lost, years lived with disability and disability-adjusted life years for 29 cancer groups, 1990 to 2016: A systematic analysis for the study of the burden global morbidity. JAMA Oncol. 41553-1568 (2018).

    PubMedGoogle Scholar Article

  • Xu, CY et al. Prognostic role of estrogen α and β receptors in gastric cancer. Anna. Surg. Oncol. 172503-2509 (2010).

    CAS PubMed Google Scholar Article

  • Qin, J. et al. The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells. Mol. Cell. Biochemistry. 39599-107 (2014).

    CAS PubMed Google Scholar Article

  • Kim, M.J. et al. Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. J. Gastr. Cancer 13172–178 (2013).

    Google Scholar article

  • Rahman, MS & Cao, J. Estrogen receptors in gastric cancer: advances and perspectives. World J. Gastroenterol. 222475–2482 (2016).

    CAS PubMed Central Google Scholar Article

  • Chandanos, E. et al. Exposure to tamoxifen in relation to the development of gastric adenocarcinoma. EUR. J.Cancer 441007-1014 (2008).

    CAS PubMed Google Scholar Article

  • Comments are closed.